| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |